Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0277-5379(91)90379-RPMID 1851619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Results of the central data analysis.

  1991cited by this paper
• Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212.

  1990cited by this paper
• Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastoma

  1989cited by this paper
• Expression of the embryonal neural cell adhesion molecule N‐CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non‐small cell lung cancer

  1989cited by this paper
• Chapter 3 Results of the central data analysis

  1988cited by this paper
• Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor.

  1988cited by this paper
• Monoclonal antibody 123C3 in lung tumour classification. Immunohistology of 358 resected lung tumours.

  1988cited by this paper
• Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron‐supporting normal tissues

  1988cited by this paper
• The L2/HNK-1 carbohydrate of neural cell adhesion molecules is involved in cell interactions

  1988cited by this paper
• Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumor cells

  1987cited by this paper
• Monoclonal Antibodies in Clinical and Experimental Pathology of Lung Cancer

  1987cited by this paper
• Prevalence of neuroendocrine granules in small cell lung carcinoma. Usefulness of electron microscopy in lung cancer classification

  1986cited by this paper
• The ‘grey area’ between small cell and non‐small cell lung carcinomas. Light and electron microscopy versus clinical data in 14 cases

  1986cited by this paper
• NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.

  1985cited by this paper
• Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1

  1984cited by this paper
• Quantification of the D2‐Glycoprotein in Amniotic Fluid and Serum from Pregnancies with Fetal Neural Tube Defects

  1983cited by this paper
• Adult and embryonic mouse neural cell adhesion molecules have different binding properties

  1983cited by this paper
• Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties.

  1980cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Gastric metastasis of small cell lung carcinoma: Three case reports and review of literature

  2024cites this paper
• Monoclonal antibodies to the exon 18 encoded moiety of NCAM

  2019cites this paper
• Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies

  2018cites this paper
• Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies

  2018cites this paper
• TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)

  2017cites this paper
• Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib.

  2015cites this paper
• Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer

  2015influential citation
• Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.

  2013cites this paper
• Pathology of lung cancer.

  2011cites this paper
• Chapter 12 - Tumours

  2011cites this paper
• Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer

  2011influential citation
• Inactive endosialidase-based detection of bacterial and oncofetal polysialic acid

  2010cites this paper
• The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer

  2010cites this paper
• Different expression of mimecan as a marker for differential diagnosis between NSCLC and SCLC.

  2009cites this paper
• Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications

  2009cites this paper
• Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma

  2009cites this paper
• Endobronchial ultrasound for diagnosis of synchronous primary lung cancers.

  2009cites this paper
• Lung Cancer: Overview and Classification

  2008cites this paper
• [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].

  2008cites this paper
• Nonsmall Cell Lung Carcinoma With Neuroendocrine Differentiation—An Entity of No Clinical or Prognostic Significance

  2007cites this paper
• Peripheral arterial ischemia by a primary lung tumour invading left atrium.

  2007cites this paper
• Neuroendocrine differentiation in non‐small cell lung cancer and its relation to prognosis and therapy

  2005cites this paper
• Histological and immunohistochemical study of composite neuroendocrine-exocrine carcinomas of the stomach.

  2005cites this paper
• Role of Tumour Microenvironment in Chemoresistance

  2005cites this paper
• CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact

  2005cites this paper
• Pro-Gastrin-Releasing Peptide in Patients with Benign and Malignant Diseases

  2004cites this paper
• ProGRP: a new biomarker for small cell lung cancer.

  2004cites this paper
• Clinically Useful Biomarkers

  2004cites this paper
• Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma

  2003cites this paper
• Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).

  2003cites this paper
• Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

  2003cites this paper
• Transcriptional gene expression profiling of small cell lung cancer cells.

  2003cites this paper
• Practical markers used in the diagnosis of neuroendocrine tumors

  2003cites this paper
• Pathology of lung cancer.

  2002cites this paper
• Prognostic factors in nonsmall cell lung cancer

  2002cites this paper
• Prognostic factors in non-small cell lung carcinoma.

  2002cites this paper
• Prognostic factors in non-small cell lung cancer: a decade of progress.

  2002cites this paper
• Effect of polysialic acid on the tumor xenografts implanted into nude mice

  2001cites this paper
• Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.

  2001cites this paper
• Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.

  2001cites this paper
• Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma.

  2001cites this paper
• Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer.

  2001cites this paper
• Cell adhesion molecules and oral cancer.

  2001cites this paper
• Expression of neural cell adhesion molecules (polysialylated form of neural cell adhesion molecule and L1‐cell adhesion molecule) on resected small cell lung cancer specimens: In relation to proliferation state

  2001cites this paper
• Applications of Immunohistochemistry in the Diagnosis of Endocrine Lesions

  2001cites this paper
• Immunohistochemical analysis of E-cadherin, α-catenin, β-catenin, γ-catenin, and neural cell adhesion molecule (NCAM) in chordoma

  2001cites this paper
• JLP5B9: new monoclonal antibody against polysialylated neural cell adhesion molecule is of value in phenotyping lung cancer.

  2000cites this paper
• Specific Cell Targeting for Delivery of Toxins into Small-Cell Lung Cancer Using a Streptavidin Fusion Protein Complex

  2000cites this paper
• Anormalidades en el sistema adhesivo de neoplasias pulmonares

  2000cites this paper
• Incidence and Prognostic Value of Bone Marrow Involvement in Small Cell Lung Cancer: The Role of Immunocytochemistry and Conventional Assessment

  1999cites this paper
• Expression of highly polysialylated neural cell adhesion molecule in pancreatic cancer neural invasive lesion.

  1999cites this paper
• Immunohistochemical Markers of Endocrine/Neuroendocrine Tumors

  1999cites this paper
• Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report.

  1998cites this paper
• Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.

  1998cites this paper
• Neural cell adhesion molecule expression: prognosis in 889 patients with resected non-small cell lung cancer.

  1998cites this paper
• Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.

  1998cites this paper
• Chromogranin A gene expression in non‐small cell lung carcinomas

  1998cites this paper
• Depressive reactions to lung cancer are common and often followed by a poor outcome.

  1998cites this paper
• Neuroendocrine-specific protein (NSP)-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation

  1997cites this paper
• Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.

  1997cites this paper
• A COMPARISON OF NSP‐RETICULONS WITH CONVENTIONAL NEUROENDOCRINE MARKERS IN IMMUNOPHENOTYPING OF LUNG CANCERS

  1997cites this paper
• Expression of the adherens junction protein vinculin in human basal and squamous cell tumors: relationship to invasiveness and metastatic potential.

  1997cites this paper
• Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections.

  1997cites this paper
• Implicações terapêuticas da diferenciação neuroendócrina (NE) dos carcinomas pulmonares de não pequenas células (CPNPC)**Texto em parte apresentado no 4° Congresso de Pneumologia do Norte Póvoa do Varzim, 7 de Março de 1997.

  1997cites this paper
• Paraffin immunohistochemical detection of CD56, a useful marker for neural cell adhesion molecule (NCAM), in normal and neoplastic fixed tissues

  1997cites this paper
• Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.

  1997cites this paper
• Relationship betweenTAOIandTA02polypeptides associated withlungadenocarcinomaand histocytological features

  1997cites this paper
• The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer.

  1996cites this paper
• Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 cases.

  1996cites this paper
• The neural cell adhesion molecule NCAM in multiple myeloma.

  1996cites this paper
• Neuroendocrine differentiation is an independent prognostic factor in chemotherapy‐treated nonsmall cell lung carcinoma

  1996cites this paper
• Molecular and biological factors in the prognosis of non-small cell lung cancer.

  1995cites this paper
• Prognostic factors in NSCLC. Recent experiences.

  1995cites this paper
• Clinical tumour markers in lung cancer.

  1995cites this paper
• Cell adhesion molecules 1: immunoglobulin superfamily.

  1995cites this paper
• Neural cell adhesion molecule and perineural invasion in gallbladder cancer

  1995cites this paper
• Clínica e terapêutica dos tumores neuroendócrinos do pulmão11Texto em parte apresemado no XI Congresso de Pneumologia (Coimbra, 8 de Novembro de 1995).

  1995cites this paper
• Biological prognostic factors in non-small cell lung cancer.

  1995cites this paper
• Molecular a and b biological ffactors iin tthe p prognosis

  1995cites this paper
• Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis.

  1995cites this paper
• Clinical applications of serum markers for lung cancer.

  1995cites this paper
• Differentiation markers for lung‐cancer sub‐types. A comparative study of their expression in vivo and in vitro

  1994cites this paper
• Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysis

  1994cites this paper
• Expression of N-CAM by human renal cell carcinomas correlates with growth rate and adhesive properties.

  1994cites this paper
• NCAM and lung cancer

  1994cites this paper
• Antigens, receptors and dominant oncogenes and the prognosis of non-small cell lung cancer.

  1994cites this paper
• Prognostic ffactors iin llung c cancer: T Tables a and C Comments

  1994cites this paper
• The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.

  1994cites this paper
• Biology of lung cancer.

  1994cites this paper
• Polysialic Acid of the Neural Cell Adhesion Molecule in the Human Thyroid: A Marker for Medullary Thyroid Carcinoma and Primary C‐Cell Hyperplasia An Immunohistochemical Study on 79 Thyroid Lesions

  1994cites this paper
• Characterization of tumor-associated neural cell adhesion molecule in human serum.

  1994cites this paper
• Prognostic factors in lung cancer: tables and comments.

  1994cites this paper
• Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types.

  1993cites this paper
• New treatment opportunities in non-small cell lung cancer

  1993cites this paper
• Neural cell adhesion molecule expression and clinical features in small cell lung cancer: a semi-quantitative immunohistochemical approach using an immunogold-silver staining method.

  1993cites this paper
• Reacteur a biogaz

  1993cites this paper
• Neural cell adhesion molecule and prognosis of surgically resected lung cancer.

  1993cites this paper
• Alternative splicing of neural-cell-adhesion molecule mRNA in human small-cell lung-cancer cell line H69.

  1993cites this paper
• Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer

  1993cites this paper
• Oncogenes and onco-suppressor genes in lung cancer.

  1993cites this paper